Urine antigen detection by latex agglutination test for diagnosis and assessment of initial cure of visceral leishmaniasis

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 105, Issue 5, 2011, Pages 269-272

  Salam, M A ^a   Khan, M G M ^b   Mondal, D ^b  

^a RAJSHAHI MEDICAL COLLEGE   (Bangladesh)

^b INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

Bangladesh; Diagnosis; Latex agglutination test; Sensitivity and specificity; Sodium antimony gluconate; Visceral leishmaniasis

Indexed keywords

ANTIMONY GLUCONATE;

ADOLESCENT; ADULT; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; LABORATORY TEST; LATEX AGGLUTINATION TEST; MALE; MICROSCOPY; URINALYSIS; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; ANTIGENS, PROTOZOAN; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; BANGLADESH; CASE-CONTROL STUDIES; FEMALE; HUMANS; LATEX FIXATION TESTS; LEISHMANIA; LEISHMANIASIS, VISCERAL; MALE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

NASO HEXACANTHUS;

EID: 79955039201     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2010.12.007     Document Type: Article

References (21)

1. Leishman W.B. On the possibility of the occurrence of trypanosomiasis in India. Br Med J 1903, 1:1252-1254.
2. WHO SEARO. Regional Technical Advisory Group on Kala-azar Elimination. Report of the First Meeting, Manesar, Haryana, 20-23 December 2004. WHO Project: IND CDR 714. New Delhi: World Health Organization Regional Office for South-East Asia; 2005. SEA-VBC-88. p. 4.
3. Bern C., Chowdhury R. The epidemiology of visceral leishmaniasis in Bangladesh: prospects for improved control. Indian J Med Res 2006, 123:275-288.
4. Sundar S., Rai M. Laboratory diagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol 2002, 9:951-958.
5. Sarkari B., Chance M., Hommel M. A capture ELISA for the diagnosis of visceral leishmaniasis using a monoclonal antibody against a leishmanial urinary antigen. Iran Biomed J 2005, 9:117-122.
6. Sarkari B., Chance M., Hommel M. Antigenuria in visceral leishmaniasis: detection and partial characterisation of a carbohydrate antigen. Acta Trop 2002, 82:339-348.
7. El-Safi S.H., Abdel-Haleem A., Hammad A., El-Basha I., Omer A., Kareem H.G., et al. Field evaluation of latex agglutination test for detecting urinary antigens in visceral leishmaniasis in Sudan. East Mediterr Health J 2003, 9:844-855.
8. Attar Z.J., Chance M.L., el-Safi S., Carney J., Azazy A., El-Hadi M., et al. Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis. Acta Trop 2001, 78:11-16.
9. Rijal S., Boelaert M., Regmi S., Karki B.M., Jacquet D., Singh R., et al. Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal. Trop Med Int Health 2004, 9:724-729.
10. Vilaplana C., Blanco S., Domínguez J., Giménez M., Ausina V., Tural C., et al. Noninvasive method for diagnosis of visceral leishmaniasis by a latex agglutination test for detection of antigens in urine samples. J Clin Microbiol 2004, 42:1853-1854.
11. Sundar S., Agrawal S., Pai K., Chance M., Hommel M. Detection of leishmanial antigen in the urine of patients with visceral leishmaniasis by a latex agglutination test. Am J Trop Med Hyg 2005, 73:269-271.
12. Diro E., Techane Y., Tefera T., Assefa Y., Kebede T., Genetu A., et al. Field evaluation of FD-DAT, rK39 dipstick and KATEX (urine latex agglutination) for diagnosis of visceral leishmaniasis in northwest Ethiopia. Trans R Soc Trop Med Hyg 2007, 101:908-914.
13. Boelaert M., El-Safi S., Hailu A., Mukhtar M., Rijal S., Sundar S., et al. Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent. Trans R Soc Trop Med Hyg 2008, 102:32-40.
14. Ghatei M.A., Hatam G.R., Hossini M.H., Sarkari B. Performance of latex agglutination test (KAtex) in diagnosis of visceral leishmaniasis in Iran. Iran J Immunol 2009, 6:202-207.
15. Jha T.K., Sundar S., Thakur C.P., Bachmann P., Karbwang J., Fischer C., et al. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med 1999, 341:1795-1800.
16. Sundar S., Jha T.K., Thakur C.P., Engel J., Sindermann H., Fischer C., et al. Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med 2002, 347:1739-1746.
17. Maurya R., Singh R.K., Kumar B., Salotra P., Rai M., Sundar S. Evaluation of PCR for diagnosis of Indian kala-azar and assessment of cure. J Clin Microbiol 2005, 43:3038-3041.
18. WHO. Control of the leishmaniases. Geneva: World Health Organization; 1990. Technical Report Series No. 793.
19. Chulay J.D., Bryceson A.D. Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Am J Trop Med Hyg 1983, 32:475-479.
20. Lowry, R., Vassar Stats. Clinical Calculator 1. Poughkeepsie, NY: Vassar College; ©Richard Lowry 2001-2010. [accessed 24 November 2010]. http://faculty.vassar.edu/lowry/clin1.html.
21. Sundar S., Singh R.K., Bimal S.K., Gidwani K., Mishra A., Maurya R., et al. Comparative evaluation of parasitology and serological tests in the diagnosis of visceral leishmaniasis in India: a phase III diagnostic accuracy study. Trop Med Int Health 2007, 12:284-289.